Top Markets
Coin of the day
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.

CPIX
Classifica tra le azioni #21215
Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical... Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets. The company's existing product line includes: Acetadote: an injectable solution for treating acetaminophen poisoning. Caldolor: an injectable medication for managing pain and fever. Kristalose: a prescription oral laxative solution effective for chronic and acute constipation. Omeclamox-Pak: used in the treatment of Helicobacter pylori infection and duodenal ulcer disease. Vaprisol: an injectable therapy for euvolemic and hypervolemic hyponatremia. Vibativ: an injectable antibiotic prescribed for severe bacterial infections, including those acquired in hospitals or associated with ventilators, as well as complex skin and skin structure infections. In its development pipeline, Cumberland is advancing: RediTrex injection: designed to treat active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, along with disabling psoriasis. Ifetroban: a product candidate currently in Phase II clinical trials for aspirin-exacerbated respiratory disease, systemic sclerosis, and Duchenne muscular dystrophy. It has also completed Phase II clinical trials for hepatorenal syndrome and portal hypertension, with further clinical investigation ongoing for its potential use in progressive fibrosing interstitial lung diseases. An additional product candidate in Phase II clinical trials, aimed at reducing cholesterol levels for hospital use. Founded in 1999, the company's corporate headquarters are located in Nashville, Tennessee.
Prezzo delle azioni
$7.51
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$112.52M
Variazione (1 giorno)
0.13%
Variazione (1 anno)
128.27%
Paese
US
Scambia Cumberland Pharmaceuticals Inc. (CPIX)

Categoria

Il prezzo CPIX con la capitalizzazione del mercato della B
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.
CPIX
$7.51
Capitalizzazione di mercato di Cumberland Pharmaceuticals Inc.(CPIX)
Capitalizzazione di mercato: $112.52M
A partire dal August 2026, Cumberland Pharmaceuticals Inc. ha una capitalizzazione di mercato pari a $112.52M. Questo rende Cumberland Pharmaceuticals Inc. la 21215th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Cumberland Pharmaceuticals Inc. dal 2009 al 2026
CPIX in paragone con la classifica dei più popolari stocks
Il prezzo per CPIX Attivo B Capitalizzazione del mercato a B Risultati
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.
$347,818 $112.52M
$5.211T +4,631,296.87%
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.
$303,460 $112.52M
$4.547T +4,040,639.69%
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.
$277,813 $112.52M
$4.162T +3,699,134.99%
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.
$239,791 $112.52M
$3.593T +3,192,849.89%
Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals Inc.
$186,401 $112.52M
$2.793T +2,481,938.22%